지혈제 시장 : 유형별, 제형별, 용도별 - 세계 예측(2025-2030년)

The Hemostats Market was valued at USD 3.23 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 5.65%, to USD 4.75 billion by 2030.

The scope and definition of hemostats pertain to medical devices or substances utilized to arrest bleeding in surgical and trauma scenarios by promoting the coagulation of blood. Hemostats are essential in both elective and emergency surgical procedures to enhance patient recovery times and outcomes, particularly in cardiovascular surgery, trauma care, and certain types of organ transplants. The end-use scope extends across hospitals, ambulatory surgical centers, and specialty clinics, with an increasing demand observed in military and trauma centers globally. Market insights reveal that the hemostats market is predominantly driven by a rise in surgical procedures, coupled with advancements in healthcare infrastructure, particularly in emerging economies. Technological innovations, such as the development of biodegradable hemostats and products suited for minimally invasive procedures, offer potential opportunities for businesses to expand their offerings. Key growth factors include an aging population, a rise in chronic conditions that necessitate surgical intervention, and increased healthcare spending across developing regions. However, substantial limitations persist, including stringent regulatory requirements, potential side effects, and the high cost of advanced hemostatic products, which may hinder market growth. Additionally, competition from alternative wound care and blood styptic products can negatively impact market expansion. The best areas for innovation include the development of next-generation hemostats with enhanced biocompatibility, faster action, and fewer adverse effects, as well as investment in research exploring the use of hemostats in novel surgical techniques. Additionally, creating sustainable, cost-effective solutions can broaden access in low-resource settings, providing untapped market potential. The competitive nature of the market demands strategic partnerships and collaborations with research institutions to stay ahead. In conclusion, while promising opportunities abound, companies must navigate regulatory landscapes and invest in R&D to address challenges and seize growth prospects effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemostats Market

The Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic disorders with increasing need for surgical interventions
  • Growing inclination toward minimally invasive surgeries
• Market Restraints
  • Rising incidences of product recalls
• Market Opportunities
  • Rise of biopolymer-based disposable hemostats
  • Integration of nanotechnology to create more efficient and targeted hemostats
• Market Challenges
  • Risk of infection and cross contamination associated with the use of hemostats tools and reagents

Porter's Five Forces: A Strategic Tool for Navigating the Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemostats Market

A detailed market share analysis in the Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemostats Market

A strategic analysis of the Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, and Thrombin-Based Hemostats.
• Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
• Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery, Orthopedic Surgery, and Reconstructive Surgery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
    • 5.1.1.2. Growing inclination toward minimally invasive surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. Rising incidences of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise of biopolymer-based disposable hemostats
    • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
  • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
  • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hemostats Market, by Type

• 6.1. Introduction
• 6.2. Collagen-Based Hemostats
• 6.3. Combination Hemostats
• 6.4. Gelatin-Based Hemostats
• 6.5. Oxidized Regenerated Cellulose-Based Hemostats
• 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

• 7.1. Introduction
• 7.2. Matrix & Gel Hemostats
• 7.3. Powder Hemostats
• 7.4. Sheet & Pad Hemostats
• 7.5. Sponge Hemostats

8. Hemostats Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Surgery
• 8.3. General Surgery
• 8.4. Gynecological Surgery
• 8.5. Neurological Surgery
• 8.6. Orthopedic Surgery
• 8.7. Reconstructive Surgery

9. Americas Hemostats Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hemostats Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
  • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
  • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
  • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
  • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
  • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
  • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
  • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
  • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
  • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A.R. Medicom, Inc.
• 2. ACTEON Group
• 3. Advamedica Inc.
• 4. Advanced Medical Solutions Group PLC
• 5. Advin Health Care
• 6. Aegis Lifesciences Private Limited
• 7. Argon Medical Devices
• 8. B. Braun SE
• 9. Baxter International Inc.
• 10. Becton, Dickinson and Company
• 11. Betatech Medical
• 12. Convatec Group PLC
• 13. Cook Group Incorporated
• 14. Cortis Medtech Pvt Ltd
• 15. Cotran Corporation
• 16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
• 17. Dynarex Corporation
• 18. Gelita AG
• 19. Hangzhou Singclean Medical Products Co.,Ltd.
• 20. Healthium Medtech Ltd
• 21. Hemostasis, LLC
• 22. Integra LifeSciences Holdings Corporation
• 23. Johnson & Johnson Services, Inc.
• 24. Medcura, Inc.
• 25. Medline Industries, LP
• 26. Medprin Biotech GmbH
• 27. Medtronic PLC
• 28. Meril Life Sciences Pvt. Ltd.
• 29. Olympus Corporation
• 30. Pfizer Inc.
• 31. Rousselot BV by Darling Ingredients International Holding B.V.
• 32. Royal DSM
• 33. Shilpa Medicare Limited
• 34. Stapleline Medizintechnik GmbH
• 35. Stryker Corporation
• 36. SYMATESE
• 37. Teleflex Incorporated
• 38. Terumo Corporation
• 39. Zhejiang Perfectseal New Material Technology Co., Ltd.
• 40. Zimmer Biomet Holdings, Inc.